Blinded side-to-side comparison of topical corticosteroid and tacrolimus ointment in children with moderate to severe atopic dermatitis

Clinical and Experimental Dermatology

Volumn 32, Issue 2, 2007, Pages 145-147

  Arkwright, P D ^a,b   Gillespie, M C ^a   Ewing, C I ^a   David, T J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b BOOTH HALL CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE VALERATE; CLOBETASONE BUTYRATE; CORTICOSTEROID; FLUOCINOLONE ACETONIDE; HYDROCORTISONE; HYDROCORTISONE BUTYRATE; MOMETASONE FUROATE; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; COVARIANCE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OINTMENT; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; TOPICAL TREATMENT; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADRENAL CORTEX HORMONES; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; PROSPECTIVE STUDIES; TACROLIMUS;

EID: 33846909055     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2006.02313.x     Document Type: Article

References (8)

1. National Institute for Clinical Excellence. Atopic dermatitis (eczema) - pimecrolimus and tacrolimus. Technology Appraisal TA082, 2004. Available at: http://www.nice.org.uk/TA082guidance.
2. Reitamo S, Harper J, Bos JD et al. 0.03% tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomised double-blind controlled trial. Br J Dermatol 2004; 150: 554-62.
3. Reitamo S, Van Leent EJ, Ho V et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 2002; 109: 539-46.
4. Reitamo S, Rustin M, Ruzicka T et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol 2002; 109: 547-55.
5. Reitamo S, Ortonne JP, Sand C et al. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis. Br J Dermatol 2005; 152: 1282-9.
6. Williams HC, Burney PG, Hay RJ et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994; 131: 383-96.
7. Ainley-Walker PF, Patel L, David TJ. Side to side comparison of topical treatment in atopic dermatitis. Arch Dis Child 1998; 79: 149-52.
8. Ruzicka T, Bieber T, Schopf E et al. A short-term trial of tracrolimus ointment for atopic dermatitis. N Engl J Med 1997; 337: 816-21.